Feedback / Questions
berubicin (RTA 744) - CNS Pharma, WPD Pharma
https://www.prnewswire.com/news-releases/cns-pharmaceuticals-announces-brain-cancer-patient-from-berubicin-phase-1-trial-remains-cancer-free-301015066.html
Mar 3, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next